Resources Contact Us Home
Modified factor VIII

Image Number 3 for United States Patent #7012132.

Specific amino acid loci of human factor VIII interact with inhibitory antibodies of hemophilia patients who have developed such antibodies after being treated with factor VIII. Modified factor VIII is disclosed in which the amino acid sequence is changed by a substitution at one or more of the specific loci. The modified factor VIII is not inhibited by inhibitory antibodies against the A2 or C2 domain epitopes. The modified factor VIII is useful for hemophiliacs, either to avoid or prevent the action of inhibitory antibodies.

  Recently Added Patents
Display apparatus having a semi-penetration layer and a sealing unit
Nestable shallow container
Compositions, organisms, systems, and methods for expressing a gene product in plants using SCBV expression control sequences operable in monocots and dicots
Client-managed group communication sessions within a wireless communications system
Method and composition for hyperthermally treating cells
Battery structures and related methods
Context data in UPNP service information
  Randomly Featured Patents
Self-checking system for electronic processing equipment
Multi-function wireless terminal
Method for measurement of tissue factor in high sensitivity and measurement kit therefor
Fuel octane responsive internal combustion engine ignition system
Automatic image correction providing multiple user-selectable options
Machine for manufacturing corrugated paperboard with independently controlled pressure applicators
Method and apparatus for data backup and restoration in a portable data device
Fluid energy delivery burst cartridge
Car door latch mechanism viewing tool
Method of and apparatus for manufacturing methanol